Damora Therapeutics (DMRA) Non-cash Items (2020 - 2026)

Damora Therapeutics (DMRA) has 6 years of Non-cash Items data on file, last reported at $11.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items changed N/A year-over-year to $11.4 million; the trailing twelve-month figure through Mar 2026 stood at $11.4 million (changed N/A YoY), and the FY2025 full-year result was $8.5 million, changed N/A from the prior year.
• Non-cash Items for Q1 2026 stood at $11.4 million, up from $8.5 million in the prior quarter.
• Across five years, Non-cash Items topped out at $11.4 million in Q1 2026 and bottomed at $2400.0 in Q3 2022.
• The 4-year median for Non-cash Items is $2.3 million (2023), against an average of $4.2 million.
• The widest annual swing landed in 2022, when Non-cash Items sank 99.88%; it then jumped 320.32% in 2023.
• A 4-year view of Non-cash Items shows it stood at $2400.0 in 2022, then jumped by 135575.38% to $3.3 million in 2023, then soared by 160.35% to $8.5 million in 2025, then soared by 34.73% to $11.4 million in 2026.
• The last three Non-cash Items figures came in at $11.4 million (Q1 2026), $8.5 million (Q4 2025), and $3.3 million (Q2 2023), per Business Quant data.

Peer Comparison